Canadian Drugmaker Apotex Seeks Up to $730 Million in First-Half IPO
· Financial Post
(Bloomberg) — Canadian generic drug manufacturer Apotex Inc. is looking at the first half of the year for an initial public offering in Toronto that could raise as much as C$1 billion ($730 million), according to people familiar with the matter. Read More
Visit asg-reflektory.pl for more information.